BioDlink International Company Limited (Stock Code: 1875) and WuXi XDC Cayman Inc. (Stock Code: 2268) have released a Composite Offer and Response Document dated 12 February 2026 regarding voluntary conditional cash offers. Citigroup Global Markets Asia Limited is acting on behalf of WuXi XDC. The document outlines terms and conditions for acquiring all issued shares of BioDlink International (excluding shares already owned or agreed to be acquired by WuXi XDC and its concert parties), as well as an offer to cancel outstanding share options.

The share offer price is set at HK$4.00 in cash per share, subject to an acceptance level that results in WuXi XDC holding at least 60% of the voting rights in BioDlink International. If fully accepted, the total consideration could reach approximately HK$3.1 billion. The transaction also includes an option offer to cancel all outstanding share options at HK$1.7665 per option, calculated as the “see-through” price.

The Composite Document provides procedures for acceptance, including completion of the relevant forms on or before 13 March 2026 (unless extended). It also states plans to maintain BioDlink International’s listing status on the Stock Exchange, subject to regulatory requirements and the necessary public float percentage. Interested parties are advised to review details in the official document for specific schedules and acceptance procedures.